You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Disease-modifying anti-rheumatic drugs

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in Singapore (Musculoskeletal ultrasound program)

Completed
  • Rheumatoid Arthritis
  • Musculoskeletal ultrasound program
  • Singapore, Singapore
    (unnamed)
Oct 25, 2020

Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Pondicherry, India
    Department of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021

Active Polyarticular Juvenile Idiopathic Arthritis Trial in Worldwide (Abatacept)

Active, not recruiting
Has Results
  • Active Polyarticular Juvenile Idiopathic Arthritis
  • Abatacept
  • Birmingham, Alabama
  • +54 more
Nov 17, 2021

Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo)

Recruiting
  • Psoriatic Arthritis
  • Jonesboro, Arkansas
  • +127 more
Aug 12, 2022

Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo, Apremilast)

Recruiting
  • Psoriatic Arthritis
  • Birmingham, Alabama
  • +136 more
Jul 29, 2022

Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Curitiba, Parana, Brazil
  • +42 more
Aug 30, 2021

Arthritis, Psoriatic Trial in Worldwide (Placebo matching BMS-945429, BMS-945429)

Completed
Has Results
  • Arthritis, Psoriatic
  • Placebo matching BMS-945429
  • BMS-945429
  • San Diego, California
  • +48 more
Oct 7, 2021

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs

Completed
  • Arthritis, Rheumatoid
    • Tokyo, Japan
      Pfizer
    Nov 28, 2022

    COVID-19 in Rheumatic Inflammatory Diseases Under

    Active, not recruiting
    • Chronic Inflammatory Rheumatism
    • Biological samples
    • Montpellier, Occitanie, France
      Centre hopsitalier universitaire de Montpellier
    Jun 10, 2022

    The Norwegian Antirheumatic Drug Register

    Recruiting
    • Inflammatory Joint Diseases
      • Drammen, Buskerud, Norway
      • +5 more
      Aug 19, 2022

      Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

      Recruiting
      • Rheumatoid Arthritis
      • +3 more
        • Barcelona, Spain
          Hospital de la Santa Creu i Sant Pau
        Apr 25, 2022

        Stellate Ganglion, Parkinson Disease Trial in Guangzhou (Treatment (Stellate ganglion block;Oral standard anti-Parkinson's

        Recruiting
        • Stellate Ganglion
        • Parkinson Disease
        • Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）
        • Treatment （Oral standard anti-Parkinson's drugs）
        • Guangzhou, Guangdong, China
          Zhujiang Hospiatal
        Oct 26, 2023

        Rheumatoid Arthritis Trial in Dhaka (Vitamin D3)

        Completed
        • Rheumatoid Arthritis
        • Vitamin D3
        • Dhaka, Bangladesh
          BSMMU
        Feb 1, 2022

        Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))

        Not yet recruiting
        • Rheumatoid Arthritis
        • Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
        • (no location specified)
        Nov 12, 2021

        d in the Treatment of Multiple Sclerosis

        Not yet recruiting
        • Multiple Sclerosis
        • Measurement of concentrations of orally-used DMDs
        • +3 more
        • Ostrava, Moravian-Silesian Region, Czechia
        • +1 more
        Dec 5, 2022

        Ankylosing Spondylitis Trial in Guangzhou (Yisaipu®)

        Completed
        • Ankylosing Spondylitis
        • Guangzhou, Guangdong, China
          Nanfang Hospital
        Aug 21, 2019

        Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)

        Recruiting
        • Rheumatic Arthritis
        • Berlin, Germany
        • +5 more
        Mar 1, 2022

        Rheumatic Diseases, Mood Disorders Trial in Besançon (Blood sample)

        Recruiting
        • Rheumatic Diseases
        • Mood Disorders
        • Blood sample
        • Besançon, France
          University Hospital
        Apr 5, 2022

        Parkinson's Disease, Overactive Bladder, Onabotulinumtoxin A Trial in Guangzhou (oral anti-Parkinson drugs and injection of

        Recruiting
        • Parkinson's Disease
        • +2 more
        • oral anti-Parkinson drugs and injection of botulinum toxin
        • oral anti-Parkinson's drugs
        • Guangzhou, Guangdong, China
          Zhujiang Hospital of Southern Medical University
        Aug 16, 2023

        Chronic Rhinosinusitis With Nasal Polyps Trial (Mepolizumab 100 MG Injection)

        Not yet recruiting
        • Chronic Rhinosinusitis With Nasal Polyps
        • Mepolizumab 100 MG Injection
        • (no location specified)
        Jun 16, 2023

        Moderated to Severe Rheumatoid Arthritis Who Have Failed to

        Completed
        • Arthritis, Rheumatoid
          • Ilsan, Gyeonggi-do, Korea, Republic of
          • +14 more
          Dec 14, 2020

          Rheumatoid Arthritis, Arthritis, Rheumatoid, Arthritis Trial in United States (Imvotamab, Placebo)

          Recruiting
          • Rheumatoid Arthritis
          • +2 more
          • Anniston, Alabama
          • +6 more
          Oct 11, 2023

          Adherence Rate to DMARDS in Egyptian Patients With RA

          Unknown status
          • Rheumatoid Arthritis
            • (no location specified)
            Jul 2, 2019

            Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)

            Recruiting
            • Rheumatic Diseases
            • Hepatitis A vaccine
            • Diphtheria, pertussis, and tetanus booster vaccine
            • Portland, Oregon
              Oregon Health & Science University
            Sep 14, 2022